ArsenalBio Raises $325M in Series C, One of 2024's Largest Biotech Funding Rounds

Sep 4, 2024, 02:33 PM

ArsenalBio has successfully raised $325 million in a Series C financing round, marking one of the largest biotech funding rounds of the year. This investment will support the company's ongoing development efforts and scale its manufacturing capabilities for T-cell medicines. The funding round ranks as the fourth largest biotech raise of 2024, following Xaira Therapeutics' $1 billion, Mirador Therapeutics' $400 million, and Formation Bio's $372 million. ArsenalBio expressed gratitude to both new and existing investors for their support.